Episode
How a 25-Cent Pill Became a Hundred-Billion-Dollar Business
- Podcast
- Paper Trail
- Published
- Jun 11, 2026
- Duration seconds
- 2485
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/paper-trail-7800276/episodes/how-a-25-cent-pill-became-a-hundred-billion-dollar-business/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/paper-trail-7800276/how-a-25-cent-pill-became-a-hundred-billion-dollar-business.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Reporter David Armstrong was diagnosed with cancer and soon learned that one of his drugs would cost almost $1,000 per pill. He set out to discover why, and uncovered financial records and legal filings that shocked him. The drugmaker’s strategy to raise the price over and over again helps explain why our healthcare system is the most expensive in the world. Read the original reporting: https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma Support our journalism by donating at propublica.org/donate .